Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia
Open accessThe DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Significance: Natural killer (NK) cells are effectors of the antitumor immunity, able to kill cancer cells through the release of the cytotoxic protease granzyme B. NK-based therapies have recently emerged as promising anticancer strategies. It is well established that hypoxic microenvironment interferes with the function of antitumor immune cells and constitutes a major obstacle for cancer immunotherapies. We showed that breast cancer cells evade effective NK-mediated killing under hypoxia by activating autophagy that we have identified to be responsible for the degradation of NK-derived granzyme B. We demonstrated that blocking autophagy restored NK-mediated lysis in vitro, and facilitated breast tumor elimination by NK cells in mice. We provided evidence that targeting autophagy may pave the way to achieve more effective NK-based anticancer immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Similarly, enhanced levels of autophagy in malignant cells are favored by a hypoxic environment, which in turn correlates with increased resistance of tumor cells to natural killer (NK)‐mediated lysis through multipronged mechanisms (Baginska et al, 2013; Tittarelli et al, 2015).”
From Autophagy in major human diseases (2021) · cites this paper as Baginska et al, 2013
In the citing paper
“Hypoxia and HIF-mediated activation of autophagy in tumor cells also regulates natural killer (NK) cell–mediated antitumor responses; this occurs through the hypoxic degradation of NK-derived granzyme B in autophagosomes and the induction of inositol 1,4,5-trisphosphate receptor, type 1”
From Hypoxic control of metastasis (2016) · cites this paper as [55]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
The tumor microenvironment and its role in promoting tumor growth
Whiteside, T. L. (2008) · Oncogene · doi:10.1038/onc.2008.271 · Cited by 2,376 · cited 1×
“The TME is a complex, dynamic structure composed of malignant cells and cells that influence cancer evolution, such as endothelial and immune cells (2).”
BackgroundSelective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy
Kärre, K., Ljunggren, H. G., Piontek, G., & Kiessling, R. (1986) · Nature · doi:10.1038/319675a0 · Cited by 2,161 · cited 1×
“The loss of HLA class I expression and the up-regulation of MICA/B and ULBP1 is a common characteristic of tumors (13), which makes them targets for NK-mediated lysis (14).”
BackgroundAutophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice
Michaud, M., Martins, I., Sukkurwala, A. Q., Adjemian, S., Ma, Y., Pellegatti, P., Shen, S., Kepp, O., Scoazec, M., Mignot, G., et al. (2011) · Science · doi:10.1126/science.1208347 · Cited by 1,377 · cited 5×
“The TME is an important aspect of cancer biology, as it can promote neoplastic transformation, support tumor growth and invasion, protect tumors from host immunity, foster therapeutic resistance, and provide niches for dormant metastases (3).”
BackgroundInfluentialCancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324 · cited 1×
“T major obstacle to defining an efficient immunotherapy protocol for the treatment of solid tumors is the capacity of the tumor microenvironment (TME) to inhibit the host immune response at both the local and systemic levels (1).”
BackgroundThe polarization of immune cells in the tumour environment by TGFβ
Flavell, R. A., Sanjabi, S., Wrzesinski, S. H., & Licona-Limón, P. (2010) · Nature Reviews Immunology · doi:10.1038/nri2808 · Cited by 940
Bryceson, Y. T., March, M. E., Ljunggren, H.-G., & Long, E. O. (2006) · Blood · doi:10.1182/blood-2005-04-1351 · Cited by 863 · cited 1×
“They can kill tumor cells directly via the engagement of death receptors [Fas and TRAIL (Tumor necrosis factor-Related Apoptosis-Inducing Ligand)] and the release of perforin- and granzyme-containing granules; or indirectly via antibody-dependent cell-mediated cytotoxicity (5, 6).”
BackgroundDifferential Tumor Surveillance by Natural Killer (Nk) and Nkt Cells
Smyth, M. J., Thia, K. Y. T., Street, S. E. A., Cretney, E., Trapani, J. A., Taniguchi, M., Kawano, T., Pelikan, S. B., Crowe, N. Y., & Godfrey, D. I. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.4.661 · Cited by 829 · cited 1×
“They can kill tumor cells directly via the engagement of death receptors [Fas and TRAIL (Tumor necrosis factor-Related Apoptosis-Inducing Ligand)] and the release of perforin- and granzyme-containing granules; or indirectly via antibody-dependent cell-mediated cytotoxicity (5, 6).”
BackgroundNew aspects of natural-killer-cell surveillance and therapy of cancer
Smyth, M. J., Hayakawa, Y., Takeda, K., & Yagita, H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc928 · Cited by 752 · cited 2×
“autophagy: A new player in cancer immunotherapy? Autophagy 8(4):704–706.”
BackgroundPrognostic value of intratumoral natural killer cells in gastric carcinoma
Ishigami, S., Natsugoe, S., Tokuda, K., Nakajo, A., Che, X., Iwashige, H., Aridome, K., Hokita, S., & Aikou, T. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000201)88:3<577::aid-cncr13>3.0.co;2-v · Cited by 586
Prospects for the use of NK cells in immunotherapy of human cancer
Ljunggren, H.-G., & Malmberg, K.-J. (2007) · Nature Reviews Immunology · doi:10.1038/nri2073 · Cited by 543 · cited 1×
“Extensive efforts have been made in recent years to identify these mechanisms (28).”
BackgroundTumor Microenvironment Complexity: Emerging Roles in Cancer Therapy
Swartz, M. A., Iida, N., Roberts, E. W., Sangaletti, S., Wong, M. H., Yull, F. E., Coussens, L. M., & DeClerck, Y. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-0122 · Cited by 542 · cited 2×
“to use thermal therapy in the treatment of cancer? Int J Hyperthermia 26(3):232–246.”
BackgroundMethodSceneay, J., Chow, M. T., Chen, A., Halse, H. M., Wong, C. S. F., Andrews, D. M., Sloan, E. K., Parker, B. S., Bowtell, D. D., Smyth, M. J., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3873 · Cited by 364
Thiery, J., Keefe, D., Boulant, S., Boucrot, E., Walch, M., Martinvalet, D., Goping, I. S., Bleackley, R. C., Kirchhausen, T., & Lieberman, J. (2011) · Nature Immunology · doi:10.1038/ni.2050 · Cited by 314 · cited 1×
“” Subsequently, perforin forms pores in the gigantosomemembrane, allowing for the gradual release of GzmB (33).”
BackgroundSelf-citationNoman, M. Z., Janji, B., Kaminska, B., Van Moer, K., Pierson, S., Przanowski, P., Buart, S., Berchem, G., Romero, P., Mami-Chouaib, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1094 · Cited by 256 · cited 8×
“The TME is an important aspect of cancer biology, as it can promote neoplastic transformation, support tumor growth and invasion, protect tumors from host immunity, foster therapeutic resistance, and provide niches for dormant metastases (3).”
BackgroundInfluentialSelf-citationNontransgenic models of breast cancer
H Heppner, G., R Miller, F., & Malathy Shekhar, P. (2000) · Breast Cancer Research · doi:10.1186/bcr77 · Cited by 231 · cited 1×
“B16–F10 tumors have been previously reported as highly hypoxic, with a selective activation of autophagy in hypoxic zones (16), and 4T1 tumors have been reported as a suitable experimental animal model for human mammary cancer (26).”
BackgroundMénard, C., Blay, J.-Y., Borg, C., Michiels, S., Ghiringhelli, F., Robert, C., Nonn, C., Chaput, N., Taïeb, J., Delahaye, N. F., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3807 · Cited by 202
Gross, C., Koelch, W., DeMaio, A., Arispe, N., & Multhoff, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302644200 · Cited by 193 · cited 1×
“The third mechanism involves heat shock protein 70 (HSP70) bound to GzmB at the cell surface (31).”
BackgroundHypoxia Promotes Tumor Growth in Linking Angiogenesis to Immune Escape
Chouaib, S., Messai, Y., Couve, S., Escudier, B., Hasmim, M., & Noman, M. Z. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00021 · Cited by 180 · cited 2×
“Under hypoxia, tumor cells release a number of chemokines, such as endothelial monocyte-activating polypeptide II (EMAP-II) (18), vascular endothelial growth factor (VEGF) (19), endothelin 2 (20), and monocyte chemotactic”
BackgroundSelf-citationHypoxia Increases Tumor Cell Shedding of MHC Class I Chain-Related Molecule: Role of Nitric Oxide
Siemens, D. R., Hu, N., Sheikhi, A. K., Chung, E., Frederiksen, L. J., Pross, H., & Graham, C. H. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0054 · Cited by 138
Lv, L., Pan, K., Li, X.-D., She, K.-L., Zhao, J.-J., Wang, W., Chen, J.-G., Chen, Y.-B., Yun, J.-P., & Xia, J.-C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018219 · Cited by 133
van Herpen, C. M. L., van der Laak, J. A. W. M., de Vries, I. J. M., van Krieken, J. H., de Wilde, P. C., Balvers, M. G. J., Adema, G. J., & Mulder, P. H. M. D. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1524 · Cited by 104
Hypoxia-driven immunosuppression: A new reason to use thermal therapy in the treatment of cancer?
Lee, C.-T., Mace, T., & Repasky, E. A. (2010) · International Journal of Hyperthermia · doi:10.3109/02656731003601745 · Cited by 103
Autophagy Attenuates the Adaptive Immune Response by Destabilizing the Immunologic Synapse
Wildenberg, M. E., Vos, A. C. W., Wolfkamp, S. C., Duijvestein, M., Verhaar, A. P., Velde, A. A. T., van den Brink, G. R., & Hommes, D. W. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.034 · Cited by 100 · cited 1×
“Based on these data, we exclude the possibility of autophagyinduced destabilization of the immunological synapse in hypoxic tumor cells, as recently described (29).”
BackgroundTumor escape mechanisms: potential role of soluble HLA antigens and NK cells activating ligands
Campoli, M. R., & Ferrone, S. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2008.01106.x · Cited by 89
Lopez, J. A., Brennan, A. J., Whisstock, J. C., Voskoboinik, I., & Trapani, J. A. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.04.001 · Cited by 83 · cited 1×
“It is still debated whether granzymes enter via perforin pores formed at the plasma membrane or whether perforin and granzymes are endocytosed with subsequent release of granzymes from endosomes into the cytoplasm (32).”
BackgroundAn integrated view of the regulation of NKG2D ligands
Stern‐Ginossar, N., & Mandelboim, O. (2009) · Immunology · doi:10.1111/j.1365-2567.2009.03147.x · Cited by 82 · cited 6×
“The up-regulation of stress-inducible proteins on the surface of cancer cells, such as MHC class I-related chain (MIC) A and B ligands and UL16-binding proteins (ULBPs), leads to the activation of NK cells through the engagement of NKG2D (12).”
BackgroundInfluentialEndothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells.
Grimshaw, M. J., Naylor, S., & Balkwill, F. R. (2002) · PubMed · Cited by 74
Cytotoxic activity of the lymphocyte toxin granzyme B
Wowk, M. E., & Trapani, J. A. (2004) · Microbes and Infection · doi:10.1016/j.micinf.2004.03.008 · Cited by 68
Recycling endosomes contribute to autophagosome formation
Longatti, A., & Tooze, S. A. (2012) · Autophagy · doi:10.4161/auto.21486 · Cited by 65 · cited 1×
“This seems to be a prerequisite for the maturation of autophagic vacuoles, their subsequent fusionwith lysosomes, and the formation of autophagolysosome (34).”
BackgroundPaired NK cell receptors controlling NK cytotoxicity
Stanietsky, N., & Mandelboim, O. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.08.047 · Cited by 64 · cited 1×
“The function of NK cells is inhibited by the interaction between HLA class I molecules, expressed on the surface of target cells, and killer cell Ig-like receptors (KIR) and/or CD94/NKG2A, expressed on the surface of NK cells (11).”
BackgroundHypoxia-induced autophagy: A new player in cancer immunotherapy?
Noman, M. Z., Janji, B., Berchem, G., Mami-Chouaib, F., & Chouaib, S. (2012) · Autophagy · doi:10.4161/auto.19572 · Cited by 63
Self-citationDendritic cell reprogramming by the hypoxic environment
Bosco, M. C., & Varesio, L. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.023 · Cited by 40 · cited 1×
“Hypoxia also contributes to the reprogramming of dendritic cells (DCs) and perpetuates inflammation via the induction of a proinflammatory DC phenotype (17).”
BackgroundCiccone, E., Pende, D., Nannl, L., Donato, C. D., Viale, O., Beretta, A., Vitale, M., Sivori, S., Moretta, A., & Moretta, L. (1995) · International Immunology · doi:10.1093/intimm/7.3.393 · Cited by 38 · cited 1×
“HLA-class I was blocked using a mouse IgM anti-pan HLA class I A6-136 mAb (35).”
MethodKärre, K., Ljunggren, H. G., Piontek, G. E., & Kiessling, R. W. (2005) · PubMed · Cited by 28
EMAP-II-dependent lymphocyte killing is associated with hypoxia in colorectal cancer
Mm, Y., Symonds, P., Ellis, I. O., & Murray, J. C. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603299 · Cited by 15
Cited by
Levy, J. M. M., Towers, C. G., & Thorburn, A. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.53 · Cited by 2,526
Autophagy in major human diseases
Klionsky, D. J., Petroni, G., Amaravadi, R. K., Baehrecke, E. H., Ballabio, A., Boya, P., Bravo‐San Pedro, J. M., Cadwell, K., Cecconi, F., Choi, A. M. K., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2021108863 · Cited by 1,585
Rankin, E. B., & Giaccia, A. J. (2016) · Science · doi:10.1126/science.aaf4405 · Cited by 1,340
Perforin and granzymes: function, dysfunction and human pathology
Voskoboinik, I., Whisstock, J. C., & Trapani, J. A. (2015) · Nature Reviews Immunology · doi:10.1038/nri3839 · Cited by 1,327
HIF transcription factors, inflammation, and immunity
Palazon, A., Goldrath, A. W., Nizet, V., & Johnson, R. S. (2014) · Immunity · doi:10.1016/j.immuni.2014.09.008 · Cited by 1,195
“, 2011) and natural killer (NK) cells (Baginska et al., 2013).”
Background
Metadata
- Authors
- Baginska, J., Viry, E., Berchem, G., Poli, A., Noman, M. Z., van Moer, K., Medves, S., Zimmer, J., Oudin, A., Niclou, S. P., Bleackley, R. C., Goping, I. S., Chouaib, S., & Janji, B.
- Affiliations
- Laboratory of Experimental Hemato-Oncology, Department of Oncology, and
- Laboratory of Immunogenetics and Allergology, Public Research Center for Health, L-1526 Luxembourg City, Luxembourg;
- Inserm (FR)
- Centre de Recherche Public de la Santé (LU)
- University of Alberta (CA)
- Institut National de la Santé et de la Recherche Médicale Unit 753, Institut de Cancérologie Gustave Roussy, F-94805 Villejuif Cedex, France;
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2013-10-07
- Volume
- 110
- Issue
- 43
- Pages
- 17450-17455
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3808626
- OpenAlex
- W2005202415
- Cited by
- 344
- References
- 36
- Citations by year
- 2026: 24 · 2025: 30 · 2024: 29 · 2023: 35 · 2022: 35 · 2021: 41 · 2020: 42 · 2019: 27 · 2018: 20 · 2017: 12 · 2016: 28 · 2015: 12 · 2014: 8 · 2013: 1
- FWCI
- 9.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Open Repository and Bibliography (University of Luxembourg) (submittedVersion, cc-by-nc-nd)
- Funders
- Fondation Cancer
- Ligue Contre le Cancer
- Universitetet i Bergen
- Institut National Du Cancer
- Canadian Institutes of Health Research
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Cell Function and Interaction
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- granzyme B, autophagy, hypoxia, natural killer cells, NK cell-mediated lysis, breast cancer, Beclin-1, autophagosomes, tumor immune evasion, NK cell therapy, antitumor immunity
- MeSH terms
- Beclin-1, Animals, Autophagy, Cells, Cultured, Cytotoxicity, Immunologic, Female, Flow Cytometry, Humans, Killer Cells, Natural, Membrane Proteins, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasms, Neoplasms, Experimental, Phagosomes, Transplantation, Heterologous, Immunoblotting, Cell Hypoxia, Microscopy, Confocal, Cell Line, Tumor, Tumor Burden, Apoptosis Regulatory Proteins, Mice, Granzymes, Time-Lapse Imaging, MCF-7 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.